Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 96 Pancreatic Neoplasms 85 Carcinoma, Non-Small-Cell Lung 79 Ovarian Neoplasms 52 Fallopian Tube Neoplasms 48 Triple Negative Breast Neoplasms 42 Lung Neoplasms 32 Neoplasm Metastasis 27 Squamous Cell Carcinoma of Head and Neck 23 Neoplasms 19 Breast Neoplasms, Male 18 Endometrial Neoplasms 17 Uterine Cervical Neoplasms 16 Stomach Neoplasms 16 Melanoma 16 Brenner Tumor 16 Carcinoma, Ovarian Epithelial 15 Esophageal Neoplasms 14 Adenocarcinoma of Lung 13 Inflammatory Breast Neoplasms 11 Cholangiocarcinoma 10 Adenocarcinoma, Bronchiolo-Alveolar 9 Urinary Bladder Neoplasms 8 Unspecified Adult Solid Tumor, Protocol Specific 8 Oropharyngeal Neoplasms 8 Carcinoma, Transitional Cell 8 Adenocarcinoma Of Esophagus 8 Mouth Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Colorectal Neoplasms 7

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 3 Pancreaticoduodenectomy 2 Oxaliplatin 2 Irinotecan 2 titanium silicide 1 tislelizumab 1 sonidegib 1 paricalcitol 1 mitazalimab 1 lenvatinib 1 ivosidenib 1 irinotecan sucrosofate 1 glucoraphanin 1 devimistat 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Taxes 1 Specimen Handling 1 Saline Solution 1 S 1 (combination) 1 Ropivacaine 1 Robotic Surgical Procedures 1 Radiomics 1 Positron Emission Tomography Computed Tomography 1 Parturition 1 PEGPH20 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Losartan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Ductal Adenocarcinoma × Taxes × Clear all

NCT04827953 2024-12-30

NUMANTIA

Nelum Corp

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡